Philippine Drug Prices Reductions effective August 15 and September 15, 2009

Tags: Reduced drug prices in Philippines August 2009, detailed list,actual prices, Prescription Drugs/Medications in the Philippines Drugstores, Drugs in the Philippines,Generic drugstores Philippines counterfeit drugs philippines, discount card philippines, drug card philippines, drug cost Philippines, Drug store philippines, drugs available Philippines, Drugstores,expired drugs philippines, generic drugs philippines, Generic drugstores Philippines, Lipitor Philippines, living in the philippines, medication card philippines, medications philippines, mercury drug philippines, pharmacy philippines, philippine retirement, prescription drugs philippines, Retire in the Philippines, senior citizen philippines, sulit card — philippinetech @ 7:06 am Edit This

Although the recent price reductions mandated for five drugs here in the Philippines have been made it is hard to find a source online that indicates exactly what these prices are but I did find a source finally

Also check out the generic pharmarcies here in the Philippines at my blog

http://philippinestuff.wordpress.com/2009/07/05/generic-drugstores-in-the-philippines/

from the Drugstores Association of the Philippines

http://www.dsaph.org/

I am reprinting from their website what they have broken out in clear detail on the prices and dates effective

DATE: AUGUST 10, 2009
TO: ALL DSAP MEMBERS
FROM: NATIONAL AFFAIRS COMMITTEE
RE: IMPLEMENTATION OF MAXIMUM DRUG RETAIL PRICES FOR SELECTED DRUGS AND MEDICINES

OBJECTIVE:

THIS MEMO AIMS TO PROVIDE GUIDELINES TO DSAP MEMBERS ON THE IMPLEMENTATION OF MAXIMUM RETAIL PRICE ON SELECTED MEDICINES AS PROVIDED BY EO 821.

BACKGROUND AND FACTS:

* RA 9502 known as “The Universally Accessible Cheaper and Quality Medicine Act of 2008” provided that price regulation of medicine can be imposed by the

State.
* The President of the Philippines, upon the recommendation of the Secretary of the Department of Health has the power to impose maximum retail prices

over “any all drugs and medicines” included in the list found in the law.
* The list of drugs that can be subjected to the Maximum Drug Retail Price (MDRP) is determined based on the following premises:

1. condition that address public matters such as leading cause of morbidity and mortality;
2. drugs with high price difference compared to international price;
3. drugs that have few competitors in terms of lack of generic counterparts or lack of market access to the product;
4. drugs where innovator product is still the highest priced product, the most prescribed and/or dispensed inspite existence of cheaper versions.

* On July 27, 2009 President Gloria Macapagal Arroyo issued Executive Order 821 imposing price cuts to five (5) molecules and announcing the price

reduction of the sixteen (16) more drugs done voluntarily by the pharmaceutical companies. Price reduction is at least 50%.

* In addition to the above list, the pharmaceutical companies also committed to reduce by about 10-50% the prices of twenty-two (22) other products.

IMPLEMENTATION GUIDELINES

1. The implementation of MDRP shall commence on August 15, 2009 but sanctions shall be imposed only on September 15, 2009.

2. The MDRP shall be imposed on all retail establishments both public and private. These include drugstores, hospital, hospital pharmacies, health maintenance organization (HMOs), convenience stores, supermarkets and the like.

3. The prescribed MDRP shall serve as the ceiling for the retail price of drugs in the list. Ceiling for the reimbursement at PhilHealth.

4. The list for the mandated MDRP as provided by EO 821 is given below:

ACTIVE INGREDIENT/MOLECULE	DOSAGE STRENGHT AND FORM	MDRP (Php)
ANTI-HYPERTENSIVE
Amlodipine (including its S-isomer and all salt form)	2.5 mg tablet	9.60
	5 mg tablet	22.85
	10 mg tablet	38.50
ANTI-CHOLESTEROL
Atorvastatin	10 mg film-coated tablet	34.45
	20 mg film-coated tablet	39.13
	40 mg film-coated tablet	50.50
	80 mg film-coated tablet	50.63
	Amlodipine besilate 5 mg + Atorvastatin calcium 10 mg tablet	45.75
	Amlodipine besilate 5 mg + Atorvastatin calcium 20 mg tablet	66.25
	Amlodipine besilate 5 mg + Atorvastatin calcium 40 mg tablet	84.42
	Amlodipine besilate 5 mg + Atorvastatin calcium 80 mg tablet	89.99
	Amlodipine besilate 10 mg + Atorvastatin calcium 10 mg tablet	51.13
	Amlodipine besilate10 mg + Atorvastatin calcium 20 mg tablet	73.25
	Amlodipine besilate 10 mg + Atorvastatin calcium 40 mg tablet	91.79
	Amlodipine besilate 10 mg + Atorvastatin calcium 80 mg tablet	91.79
ANTIBIOTIC/ANTIBACTERIAL
Azithromycin and all its Salt Form	250 mg tablet	108.50
	200 mg/5 ml powder for suspension (15 ml)	427.50
	200 mg/5 ml powder for suspension (22.5 ml)	638.00
	500 mg tablet	151.43
	500 mg vial for injection	992.50
	2 g granules	468.00
ANTI-NEOPLASTICS/ ANTI-CANCER
Cytarabine	100 mg/ml ampul/vial(IV/SC)	240.00
	100 mg/ml ampul/vial(IV/SC) (5 ml) or 500 mg vial	900.00
	100 mg/ml ampul/vial(IV/SC) (10 ml) or 1g vial	1800.00
	20 mg/ml (5ml) ampul/vial for injection	1980.00
Doxorubicin and all its Salt Form	10 mg powder vial for injection	1465.75
	50 mg powder vial for injection	2265.74

5. The list under Voluntary Price Reduction scheme as provided by Resolution 2009-001 of the Advisory Council for Price Regulation is as noted in chart at end of this blog

6. Price differentials that shall result from this price reduction shall be shouldered by the corresponding manufacturer, trader or importer.

7. The price differential s shall be reimbursed or rebated to the drugstores by the manufacturers, traders or importers in the manner and procedures they deem appropriate and practical. (Attached herewith is the guidelines issued by Metro Drug Incorporated).

8. Violation of this imposition shall be dealt with penalties as mandated by the IRR of the Cheaper Medicine Bill. Penalties for violation of the MDRP shall be no less than Fifty-thousand pesos (P50,000.00) but not more than five million pesos (P5,000,000.00).

9. The list of medicine subject to MDRP shall be reviewed after three (3) to six (6) months by the DOH and as may be recommended.
DSAP ADVISORY

1. Make inventory of the products found on the list. Try to find their appropriate references such as delivery receipts and invoices.

2. Contact your suppliers and know them their respective reimbursement procedures.

3. If you are sourcing your products from wholesalers, consult with them to find out how they can help you with the reimbursement.

ACTIVE INGREDIENT/MOLECULE	DOSAGE STRENGTH AND FORM	COMPANY	OLD RETAIL PRICE	GOVERNMENT-MEDIATED ACCESS PRICE
ANTI-HYPERTENSIVE
Telmisartan	40 mg tablet	Boehringer	51.50	25.7
	Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg tablet	Boehringer	50.00	25.00
	80 mg tablet	Boehringer	89.00	44.50
	Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg tablet	Boehringer	89.00	44.50
Irbesartan	150 mg tablet	Sanofi-Aventis via Winthrop	48.76	24.38
	Irbesartan 150 mg + Hydrochlorothiazide 12.5 mg tablet	Sanofi-Aventis via Winthrop	50.26	25.13
	300 mg tablet	Sanofi-Aventis via Winthrop	80.00	40.00
	Irbesartan 300 mg + Hydrochlorothiazide 12.5 mg tablet	Sanofi-Aventis via Winthrop	83.00	41.50
ANTI-THROMBOTIC
Clopidogrel	75 mg film-coated tablet	Sanofi – Aventis	123.50	61.75
ANTI-DIABETIC/ANTIHYPOGLYCEMIC
Gliclazide	30 mg Modified Release Tablet	Servier	15.00	7.50
	80 mg tablet	Servier	15.00	7.50
ANTIBIOTIC / ANTIBACTERIAL
Piperacillin +Tazobactam and all its Salt form	Piperacillin 2 g + Tazobactam 250 mg vial	Wyeth	2175.46	730.20
	4 g + Tazobactam 500 mg vial	Wyeth	4614.00	1270.06
Ciprofloxacin and all its Salt form	500 mg tablet	Bayer	83.83	41.91
	500 mg tablet (Extended Release)	Bayer	99.23	49.62
	1 g tablet	Bayer	145.10	72.55
	250 mg tablet	Bayer	65.13	32.57
	2mg/ml (100 ml) for injection	Bayer	1884.17	942.00
	2 mg/ml (50 ml) or 100 mg IV infusion (50 ml)	Bayer	1440.87	720.43
	400 mg (20 ml) for injection	Bayer	3207.17	1603.59
Metronidazole and all its Salt form	125mg/5 ml (60 ml) suspension	Sanofi-Aventis	131.00	65.50
	500 mg tablet	Sanofi-Aventis via Winthrop	23.50	11.75
	500 mg (100 ml) IV infusion	Sanofi-Aventis	379.50	189.75
Co-Amoxiclav (Amoxicillin + Clavulanic acid)	625 mg tablet	GSK	97.75	48.90
	375 mg tablet	GSK	79.50	39.75
	1 g tablet	GSK	142.25	71.15
	600 mg vial for injection	GSK	687.50	343.75
	1.2 g vial for injection	GSK	1156.75	578.40
	Amoxicillin 200 mg + Clavulanic Acid 28.5 mg/5ml (70 ml) suspension	GSK	555.50	277.75
	Amoxicillin 125 mg + Clavulanic Acid 31.25 mg/5ml (60 ml) suspension	GSK	378.00	189.00
	Amoxicillin 250 mg + Clavulanic Acid 62.5 mg/5ml (60 ml) suspension	GSK	648.50	324.25
	Amoxicillin 400 mg + Clavulanic Acid 57 mg/5ml (70 ml) suspension	GSK	940.50	470.25
	Amoxicillin 400 mg + Clavulanic Acid 57 mg/5ml (35 ml) suspension	GSK	523.75	261.90
ANTI-NEOPLASTIC
ANTI-CANCER
Bleomycin and all its Salt form	15 mg vial/ampul for injection	Bristol-Meyer Squibb via Zuellig	9750.00	3520.00
Carboplatin	10 mg/ml (15 ml) vial or 150 mg for injection	Bristol-Meyer Squibb via Zuellig	3610.00	1805.00
Cisplatin	50 mg powder vial for injection	Bristol-Meyer Squibb via Zuellig	2804.00	1125.00
Cyclophosphamide	50 mg tablet	Bristol-Meyer Squibb via Zuellig	33.50	17.50
	200 mg vial for injection	Baxter	698.95	175.00
	500 mg vial for injection	Bristol-Meyer Squibb via Zuellig	649.00	324.50
	1 g or 1000 mg vial for injection	Qualimed	1155.00 (most expensive)	577.50
Etoposide (No innovator locally)	100 mg tablet	Qualimed	1130.00 (most expensive in the market)	565.00
Mercaptopurine	50 mg tablet	GSK	79.00	39.50
Methotrexate sodium (No innovator locally)	2.5 mg tablet	Qualimed	23.00 (most expensive brand)	11.00
	50 mg/ 2 ml vial for injection	Qualimed	612.00 (most expensive brand)	306.00
Mesna	400 mg ampul for injection	Baxter	369.00	166.67

JOSEPHINE P. INOCENCIO

National President